Latest News about NVS
Recent news which mentions NVS
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
Today 11:15 EDT
From Benzinga
Novartis Sees Hope In Reducing Lifelong Treatment Burden For Autoimmune Blood Disorder
August 12, 2025
From Benzinga
Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
August 11, 2025
From Benzinga
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
August 08, 2025
From Benzinga
From Motley Fool
3 International Dividend Stocks With High Yields
July 29, 2025
From TalkMarkets
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
July 20, 2025
From Motley Fool
Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback
July 17, 2025
From Benzinga
Earnings Scheduled For July 17, 2025
July 17, 2025
From Benzinga
From Benzinga
From TalkMarkets
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Is Pfizer Stock a Yield Trap?
July 03, 2025
From Motley Fool
From Benzinga
From Motley Fool
Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma
June 25, 2025
From Benzinga
From Benzinga
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
June 13, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.